Hepatitis B vaccine in infants: A randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 43, Issue 3, 2001, Pages 139-143

  Alves, Andrea Santos Rafael ^a   Nascimento, Cristiane M R ^a   Granato, Celso H ^b   Sato, Helena Keiko ^c   Morgato, Marina F ^d   Pannuti, Claudio S ^a,e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Department of Health   (Brazil)

^d Fleury Laboratory   (Brazil)

^e NONE   (Brazil)

Author keywords

Gluteal injection; Hepatitis B; Infant; Injection; Intramuscular; Vaccine efficacy

Indexed keywords

HEPATITIS B VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; IMMUNOGENICITY; INFANT; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SEROLOGY; THIGH; VACCINATION;

EID: 0034918413     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652001000300004     Document Type: Article

References (37)

1. CALDWELL, G.R.; REISS-LEVY, E.; & HEDGES, M.J. - Successful hepatitis B vaccination by deltoid injection after failure in the gluteal site [Letter]. Aust. N. Z. J. Med., 15: 772, 1985.
2. CANHO, R. del; GROSHEIDE, P.M.; MAZEL, J.A. et al. - Ten year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long term immunogenicity. Vaccine, 15: 1624-1630, 1997.
3. CENTERS FOR DISEASE CONTROL - Suboptimal response to hepatitis B vaccine given by injection into the buttock. M. M. W. R., 34: 105-113, 1985.
4. CHALASANI, N. & GITLIN, N. - Why do we need a newer generation of recombinant vaccines against hepatitis B? [Letter]. Amer. J. Gastroent., 92: 2314-2315, 1997.
5. CLEMENS, R.; SÄNGER, R.; KRUPPENBACHER, J. et al. - Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule -results of a post-marketing surveillance. Vaccine, 15: 349-352, 1997.
6. COCKSHOTT, W.P.; THOMPSON, G.T.; HOWLETT, L.J. & SEELEY, E.T. -Intramuscular or intralipomatous injections? New Engl. J. Med., 101: 356-358, 1982.
7. COMBES, M.A.; CLARK, W.K.; GREGORY, C.F. & JAMES, J.A. - Sciatic nerve injury in infants. Recognition and prevention of impairment resulting from intragluteal injections. J. Amer. med. Ass., 173: 1336-1339, 1960.
8. DIENSTAG, J.L.; WERNER, B.G.; POLK, B.F. et al. - Hepatitis B vaccine in health care personnel: safety, immunogenicity and indicators of efficacy. Ann. intern. Med., 101: 34-40, 1984.
9. DREHOLBL, P. - Quadriceps contracture. Amer. J. Nursing, 80: 1650-1651, 1980.
10. FUNDAÇÃO NACIONAL DE SAÜDE. MINISTÉRIO DA SAÜDE DO BRASIL -Programa Nacional de Imunizações. http://www.funasa.gov.br/imu/imu01.htm [2000, October 19].
11. a ed. Brasília, Departamento de Operações, Programa Nacional de Imunizações, 1993. p 19-20.
12. GILES, F.H. & FRENCH, J.H. - Postinjection sciatic nerve palsies in infants and children. J. Pediat., 38: 195-204, 1961.
13. HELLGREN, T.E. - Deltoid versus buttock as preferred site of injection for hepatitis B vaccine. J. Fla. med. Ass., 76: 399-402, 1989.
14. HONORATI, M.; BORZI, R.M.; DOLZANI, P.; TONEGUZZI, S. & FACCHINI, A. -Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine. Int. J. clin. Lab. Res., 27: 202-206, 1997.
15. IMMUNIZATION PRACTICES ADVISORY COMMITTEE - Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. M. M. W. R., 40: 1-19, 1991.
16. KIM, S.C.; SINAI, L.N.; CASEY, R. & PINTO-MARTIN, J.A. - Universal hepatitis B immunization. Pediatrics, 95: 764-766, 1995.
17. KLEINBAUM, D.G. - Logistic regression: a self-learning text. New York, Springer Verlag, 1994.
18. LINDSAY, K.L.; HERBERT, D.A. & GITNICK, G.L. - Hepatitis B vaccine: low postvaccination immunity in hospital personnel given gluteal injections. Hepatology, 5: 1088-1090, 1985.
19. PEAD, P.J. - Immune responses to hepatitis B vaccination in hospital staff. Biomed. Pharmacother., 40: 251-253, 1986.
20. PIGGOT, J. - Needling doubts about where to vaccinate (Letter). Brit. med. J., 297: 1130, 1988.
21. RESTI, M.; AZZARI, C.; MANNELLI, F. et al. - Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? Vaccine, 15: 1338-1340, 1997.
22. SCHAAFF, D.M.; LENDER, M.; SNEDEKER, P. & GRAHAM, L.A. - Hepatitis B vaccine in a hospital [Letter]. Ann. intern. Med., 101: 720-721, 1984.
23. SHAW, F.E.Jr.; GUESS, H.A.; ROETS, J.M. et al. - Effect of anatomic injection site, age, and smoking on the immune response to hepatitis B vaccination. Vaccine, 7: 425-430, 1989.
24. STEVENS, C.E.; TOY, P.T.; TAYLOR, P.E.; LEE, T. & YIP, H.Y. - Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics, 90: 170-173, 1992.
25. STEVENSON, W.J. - Estatística aplicada à administração. São Paulo, Harbra, 1986.
26. STRICKLER, A.C.; KIBSEY, P.C. & VELLEND, H. - Seroconversion rates with hepatitis B vaccine [Letter]. Ann. intern. Med., 101: 564, 1984.
27. SUS. MINISTÉRIO DA SAÚDE. SECRETARIA EXECUTIVA. DATASUS - Pograma Nacional de imunizações: imunizações. Doses aplicadas, segundo ano, período 1998. http://www.datasus.gov.br//cgi/pni/dpnimap.htm [2000, October 19].
28. SZMUNESS, W.; STEVENS, C.E.; HARLEY, E.J. et al. - Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. New Engl. J. Med., 303: 833-841, 1980.
29. SZMUNESS, W.; STEVENS, C.E.; HARLEY, E.J. et al. - Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. New Engl. J. Med., 307: 1481-1486, 1982.
30. THOMPSON, M.K. - Needling doubts about where to vaccinate. Brit. med. J., 297: 779-780, 1988.
31. UKENA, T.; ESBER, H.; BESSETTE, R. et al. - Site of injection and response to hepatitis B vaccine [Letter], New Engl. J. Med., 313: 579-580, 1985.
32. VAN HERCK, K.: VAN DAMME, P.; THOELEN, S. & MEHEUS, A. - Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results. Vaccine, 16: 1933-1935, 1998.
33. WAINWRIGHT, R.B.; MCMAHON, B.J.; BULKOW, L.R.; PARKINSON, A.J. & HARPSTER, A.P. - Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven year results. Arch. intern. Med., 151: 1634-1636, 1991.
34. WEBER, D.J.; RUTALA, W.A.; KENYEAR, S.A. & LEMON, S.M. - Response to deltoid muscle injection of hepatitis B vaccine after failure to respond to gluteal injections [Letter]. J. Amer. med. Ass., 255: 2157, 1986.
35. WEBER, D.J.; RUTALA, W.A.; SAMSA, G.P.; SANTIMAW, J.E. & LEMON, S.M. -Obesity as predictor of poor antibody response to hepatitis B plasma vaccine. J. Amer. med. Ass., 254: 3187-3189, 1985.
36. WEST, D.J. & MARGOLIS, H.S. - Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediat. infect. Dis. J., 11: 866-874, 1992.
37. WHO WORKING GROUP - Use and interpretation of anthropometric indicators of nutritional status. Bull. Wld. Hlth. Org., 64: 929-941, 1986.